Will Mauldin, Ph.D. — Chairman, CEO, and Co‑founder at RIVANNA — reflects on iterative paths to innovation in neuraxial ultrasound. Our ongoing collaboration with OB anesthesia providers and societies like SOAP has shaped the development of our continuous needle-tracking solutions, allowing us to tailor them to real-world clinical demands.
Bringing solutions that work to healthcare requires more than engineering. We need partnership every step of the way. 🔔 Follow us for updates on the results of this collaborative iteration.